574 related articles for article (PubMed ID: 15572382)
1. Uric acid correlates with the severity of histopathological parameters in IgA nephropathy.
Myllymäki J; Honkanen T; Syrjänen J; Helin H; Rantala I; Pasternack A; Mustonen J
Nephrol Dial Transplant; 2005 Jan; 20(1):89-95. PubMed ID: 15572382
[TBL] [Abstract][Full Text] [Related]
2. Vascular diseases and their risk factors in IgA nephropathy.
Myllymäki J; Syrjänen J; Helin H; Pasternack A; Kattainen A; Mustonen J
Nephrol Dial Transplant; 2006 Jul; 21(7):1876-82. PubMed ID: 16522659
[TBL] [Abstract][Full Text] [Related]
3. Severity of tubulointerstitial inflammation and prognosis in immunoglobulin A nephropathy.
Myllymäki JM; Honkanen TT; Syrjänen JT; Helin HJ; Rantala IS; Pasternack AI; Mustonen JT
Kidney Int; 2007 Feb; 71(4):343-8. PubMed ID: 17191083
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and risk factors of intrarenal arterial lesions in patients with IgA nephropathy.
Wu J; Chen X; Xie Y; Yamanaka N; Shi S; Wu D; Liu S; Cai G
Nephrol Dial Transplant; 2005 Apr; 20(4):719-27. PubMed ID: 15701667
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and natural history of IgA nephropathy.
Rychlik I; Andrassy K; Waldherr R; Zuna I; Tesar V; Jancová E; Stejskalová A; Ritz E
Ann Med Interne (Paris); 1999 Feb; 150(2):117-26. PubMed ID: 10392260
[TBL] [Abstract][Full Text] [Related]
6. Ambulatory blood pressure, proteinuria and uric acid in children with IgA nephropathy and their correlation with histopathological findings.
Seeman T; Pohl M; John U; Dusek J; Vondrák K; Janda J; Stejskal J; Groene HJ; Misselwitz J
Kidney Blood Press Res; 2008; 31(5):337-42. PubMed ID: 18946224
[TBL] [Abstract][Full Text] [Related]
7. Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease.
Zapolski T; Waciński P; Kondracki B; Rychta E; Buraczyńska MJ; Wysokiński A
Kardiol Pol; 2011; 69(4):319-26. PubMed ID: 21523662
[TBL] [Abstract][Full Text] [Related]
8. Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function.
Nelson CL; Karschimkus CS; Dragicevic G; Packham DK; Wilson AM; O'Neal D; Becker GJ; Best JD; Jenkins AJ
Nephrol Dial Transplant; 2005 Nov; 20(11):2420-6. PubMed ID: 16115854
[TBL] [Abstract][Full Text] [Related]
9. Glucose metabolism, insulin resistance, and renal pathology in non-diabetic chronic kidney disease.
Ikee R; Hamasaki Y; Oka M; Maesato K; Mano T; Moriya H; Ohtake T; Kobayashi S
Nephron Clin Pract; 2008; 108(2):c163-8. PubMed ID: 18259103
[TBL] [Abstract][Full Text] [Related]
10. The role of alpha-smooth muscle actin and platelet-derived growth factor-beta receptor in the progression of renal damage in human IgA nephropathy.
Ranieri E; Gesualdo L; Grandaliano G; Maiorano E; Schena FP
J Nephrol; 2001; 14(4):253-62. PubMed ID: 11506247
[TBL] [Abstract][Full Text] [Related]
11. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
[TBL] [Abstract][Full Text] [Related]
12. Fibrotic mechanisms in idiopathic rapidly progressive glomerulonephritis: the role of TGF-beta1 and C5b-9.
Gionanlis L; Alexopoulos E; Papagianni A; Leontsini M; Memmos D
Ren Fail; 2008; 30(2):239-46. PubMed ID: 18300128
[TBL] [Abstract][Full Text] [Related]
13. An important role of glomerular segmental lesions on progression of IgA nephropathy: a multivariate analysis.
Katafuchi R; Oh Y; Hori K; Komota T; Yanase T; Ikeda K; Omura T; Fujimi S
Clin Nephrol; 1994 Apr; 41(4):191-8. PubMed ID: 8026110
[TBL] [Abstract][Full Text] [Related]
14. Impact of hypertension and hypertension-related vascular lesions in IgA nephropathy.
Ikee R; Kobayashi S; Saigusa T; Namikoshi T; Yamada M; Hemmi N; Imakiire T; Kikuchi Y; Suzuki S; Miura S
Hypertens Res; 2006 Jan; 29(1):15-22. PubMed ID: 16715649
[TBL] [Abstract][Full Text] [Related]
15. Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification).
Edström Halling S; Söderberg MP; Berg UB
Nephrol Dial Transplant; 2012 Feb; 27(2):715-22. PubMed ID: 21750154
[TBL] [Abstract][Full Text] [Related]
16. Factors predicting progression of IgA nephropathies.
Coppo R; D'Amico G
J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
[TBL] [Abstract][Full Text] [Related]
17. Histomorphometric correlates of renal failure in IgA nephropathy.
Vleming LJ; de Fijter JW; Westendorp RG; Daha MR; Bruijn JA; van Es LA
Clin Nephrol; 1998 Jun; 49(6):337-44. PubMed ID: 9696428
[TBL] [Abstract][Full Text] [Related]
18. Clinical course and prognostic factors of clinical early IgA nephropathy.
Shen P; He L; Huang D
Neth J Med; 2008 Jun; 66(6):242-7. PubMed ID: 18689907
[TBL] [Abstract][Full Text] [Related]
19. An increased polymeric IgA level is not a prognostic marker for progressive IgA nephropathy.
van der Boog PJ; van Kooten C; van Seggelen A; Mallat M; Klar-Mohamad N; de Fijter JW; Daha MR
Nephrol Dial Transplant; 2004 Oct; 19(10):2487-93. PubMed ID: 15252166
[TBL] [Abstract][Full Text] [Related]
20. Urinary excretion of low-molecular-weight proteins as prognostic markers in IgA nephropathy.
Peters HP; van den Brand JA; Wetzels JF
Neth J Med; 2009 Feb; 67(2):54-61. PubMed ID: 19299847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
